InvestorsHub Logo
Post# of 251715
Next 10
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

Re: None

Thursday, 03/27/2014 8:22:45 AM

Thursday, March 27, 2014 8:22:45 AM

Post# of 251715


Baxter to split into two; shares soar
Baxter International (BAX) is splitting into two companies, with one focused on biopharmaceuticals and the other on medical products.
Baxter will make a tax-free distribution of shares in the biopharmaceuticals business to its shareholders. The company expects to complete the transaction by mid-2015.
The biopharmaceuticals business generated 2013 annual revenues of $6B and develops treatments for hemophilia and other bleeding disorders, immune deficiencies, burns and shock.
The medical-products business earned annual sales of over $9B and provides intravenous (IV) solutions and nutritional therapies, drug-delivery systems and administration sets, and premixed and other injectable drugs, as well as inhalation anesthetics and hospital-based biosurgery products.
Baxter CEO Robert Parkinson will head the medical-products company, which will retain the Baxter International name.
Ludwig Hantson, who is president of BioScience, will run the biopharmaceuticals firm.
Shares are +12.5%.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.